Sanofi Korea launched Aprovasc Tab, the first antihypertensive combination drug comprising irbesartan and amlodipine besylate co-developed with Handok on Thursday.Aprovasc won approval from the Ministry of Food and Drug Safety in November 2023 for treating essential hypertension in patients whose bl
Hanmi Pharma said it has signed a strategic agreement with its U.S. partner company, Assertio Holdings, which previously acquired Spectrum Pharmaceuticals, to re-acquire the rights to Rolontis, a long-acting neutropenia treatment and Korea's 33rd novel drug, for the Asian and African markets.Rolonti
Seoul National University Hospital (SNUH) said on Friday that YG Entertainment, a prominent K-pop entertainment agency, has contributed 100 million won ($75,358) to aid in the treatment and music rehabilitation of children with cochlear implants.The donation will be utilized to assist in covering su
Instead of surgery that requires drilling holes in the skull and inserting electrodes deep into the brain, researchers from the Institute for Basic Science (IBS) have announced a significant breakthrough in the treatment of Parkinson's disease.The team, led by Professors Cheon Jin-woo and Kwak Min-s
Takeda Korea said the National Health Insurance will reimburse its adult acquired hemophilia A (AHA) treatment Objzur Inj (susoctocog alpha) starting Thursday.Obizur is Korea's only blood clotting factor VIII treatment for adult AHA. It won the Ministry of Food and Drug Safety approval in March last
Osang Healthcare said it received approval from the Ministry of Food and Drug Safety for "GeneFinder HLA-B*58:01 Plus RealAmp Kit," designed to help better treat gout patients.The kit tests for the HLA-B5801 genetic variant, which is used to identify gout patients at risk of severe skin reactions to
BNC Korea said Thursday that it has signed a joint research and development agreement with SML Biopharm to develop a GLP1 agonist for treating diabetes and obesity using mRNA technology.Under the agreement, SML Biopharm will utilize its mRNA platform expression technology to express target genes in
Ildong Pharmaceutical has received material patents in China and Japan for its metabolic disease drug candidate, ID110521156, which is being developed through its subsidiary Yunovia.ID110521156 is the GLP-1 receptor agonist (glucagon-like peptide-1 receptor agonist) family of drugs and acts as an an
Huonce said Thursday that it has launched Dexcom G7, a continuous real-time glucose monitoring system.According to the company, Dexcom G7 is a medical device diabetic patients use to manage blood glucose. It is 60 percent smaller than previous models because the sensor and transmitter are integrated
In a significant move towards advancing digital healthcare, Kakao Healthcare, led by CEO Hwang Hee, unveiled its first service, "PASTA," an AI-based mobile blood glucose management application, on Thursday in Korea.The service was officially announced during a press conference held at Kakao Pangyo A
Samsung Bioepis and Samil Pharmaceutical have announced a marketing partnership for the local sales of SB15, a biosimilar referencing Eylea.Eylea is a blockbuster ophthalmic drug developed by Regeneron and treats wet age-related macular degeneration (wAMD) and diabetic macular edema (DME), which can
Astellas Korea's ADC (antibody-drug conjugate) drug Padcev Inj (enfortumab vedotin) has passed the Cancer Disease Review Committee (CDRC).On Wednesday, the Health Insurance Review and Assessment Service (HIRA) released the insurance benefit standard deliberation results at this year’s first CDRC mee
Merz Aesthetics Korea said it held the “MERZ AESTHETICS SERENDIPITY JOURNEY (MASJ) Symposium” with Korean aesthetic and medical professionals at the InterContinental Seoul COEX on Jan. 27.The MASJ Symposium is part of the “Beautiful Promise” campaign that Merz has been running with Korean medical pr
Biotech and healthcare companies operating in the new technology industry face limitations in investing and raising funds to increase corporate value due to their small size, burdened with “initial investment costs” and “lack of specialized manpower.”Therefore, the government should provide institut
Seoul Metro initiated a trial run of seatless subway cars on Line 4 to alleviate congestion during peak hours. This initiative reflects the competitive nature of Korean society, akin to a game of musical chairs. In this game, participants fiercely vie for a limited number of chairs, with those unabl
Pfizer Korea and Hanlim MS said they entered into a co-marketing agreement for the drug Xeljanz (ingredient: tofacitinib citrate), a drug used in the treatment of various autoimmune diseases.This collaboration aims to expand the availability and benefits of Xeljanz to a wider patient demographic thr
Over 3,000 doctors are generated annually in Korea, yet a declining number are actively seeking specialized qualifications. Particularly noteworthy is the reduction of physicians specializing in critical departments that deliver essential care, with a decrease of 610, or 24 percent, observed over th
CHA Vaccine Institute, a subsidiary of CHA Biotech, has disclosed the top-line results from the phase 1 clinical trial of its third-generation hepatitis B vaccine candidate, CVI-HBV-002, which showed that the candidate had higher efficacy compared to currently available vaccines. The announcement pr
A mother's diagnosis of breast cancer at a young age does not significantly affect her children's emotional development, according to a new study.Professor Kim Hee-jeong of the Department of Breast Surgery and Professor Kim Hyo-won of the Department of Pediatric Psychiatry at Asan Medical Center (AM
CG Bio, a regenerative medicine company, said Wednesday that it has launched Easydew MD cream 200g, which strengthens the skin barrier.The skin barrier is the outer layer of the skin that protects the skin from external threats such as infectious agents, chemicals, systemic toxins, and allergens.Eas